Data as of Dec 17
| -0.02 / -1.05%|
The 2 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 7.37, with a high estimate of 8.07 and a low estimate of 6.67. The median estimate represents a +289.81% increase from the last price of 1.89.
The current consensus among 2 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.